Modulation of brain iron by local hepcidin in prion disorders

朊病毒病中局部铁调素对脑铁的调节

基本信息

批准号：
10350851
负责人：
Neena Singh
金额：
$ 44.28万
依托单位：
CASE WESTERN RESERVE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10350851
关键词：
Affect Age Animal Model Animals Applications Grants Astrocytes Autopsy Blood Blood-Retinal Barrier Brain Brain Diseases C57BL/6 Mouse Cell Death Cell membrane Cells Cerebrum Chronic Clinical Clinical Trials Communicable Diseases Creutzfeldt-Jakob Syndrome Data Dementia Diagnostic tests Disease Disease Progression Dose Down-Regulation Evaluation Exposure to Ferritin Hamsters Harvest Homeostasis Human Interleukin-1 beta Interleukin-6 Intestines Iron Iron Overload Knock-out Laboratories Lethal Dose 50 Liver Mediating Messenger RNA Microglia Mus Nature Nerve Degeneration Neurons Oxidation-Reduction Pathogenesis Peptides Plasma PrP PrPSc Proteins Prion Diseases Process Production Protein Export Pathway Protein Isoforms Proteins Publishing Reactive Oxygen Species Regulation Retina Retinal Degeneration Retinal Ganglion Cells Role Scrapie Serum Signal Transduction Stabilizing Agents Testing Therapeutic Thick Tissues Toxic effect Transcription Coactivator Transferrin Up-Regulation base beta pleated sheet brain tissue cytokine cytotoxicity end stage disease hepcidin holotransferrin metal transporting protein 1 neuroblastoma cell neuroinflammation neuron loss neurotoxicity paracrine pre-clinical retinal imaging retinal nerve fiber layer uptake

项目摘要

Prion disorders are infectious and invariably fatal neurodegenerative conditions associated with accumulation of PrP-scrapie (PrPSc), a β-sheet rich isoform of the normal prion protein (PrPC), in the brain and retina of humans and certain animal species. Sporadic Creutzfeldt-Jakob-disease (sCJD) is the most common human prion disorder, and PrPSc-infected animal models are used to understand the mechanism of infectivity and toxicity. Neuroinflammation and iron accumulation are consistent features of these disorders, the latter contributing to neurotoxicity by iron-catalyzed reactive oxygen species (ROS). The cause of iron accumulation, however, has remained elusive. Recent data from my laboratory suggest cytokine-mediated upregulation of hepcidin synthesized by astrocytes as a significant cause. Hepcidin regulates iron by downregulating ferroportin (Fpn), the only known iron export protein. Under normal conditions, hepcidin is upregulated when iron saturation of transferrin (Tf-Fe) is low. Upregulation by cytokines, however, supersedes the signal from Tf-Fe. It is likely that cytokine-mediated upregulation of hepcidin by astrocytes is the cause of iron neuronal accumulation that express Fpn on their plasma membrane, and toxicity by ROS. In support of this hypothesis, sCJD brain homogenates show upregulation of hepcidin mRNA and protein, downregulation of Fpn, and increase in ferritin. Likewise, brain homogenates from PrPSc-infected mice show upregulation of hepcidin mRNA, and retinal sections from PrPSc- infected hamsters show activation of microglia before or concomitant with upregulation of ferritin during disease progression. Based on these observations, we hypothesize that iron accumulation in sCJD and PrPSc-infected brains and retina results from cytokine-mediated upregulation of local hepcidin. Two specific aims are proposed to test this hypothesis. In aim 1, additional sCJD brain and retinal tissue will be checked for increase in hepcidin mRNA and accumulation of iron, and correlated with neuronal and retinal ganglion cell (RGC) death in immunostained sections. In addition, the brain and retina of PrPSc-infected mice will be examined during disease progression to explore if increase in cytokines precedes upregulation of hepcidin and iron accumulation, and whether retinal degeneration precedes neurodegeneration. This will pave the way for retinal imaging a pre- clinical diagnostic test for sCJD. In aim 2, the role of hepcidin in brain and retinal iron accumulation will be further explored using hepcidin knock-out (hepc-/-) and littermate (hepc+/+) control mice inoculated with PrPSc. A significant decrease in iron accumulation in hepc-/- mice relative to hepc+/+ controls despite similar increase in cytokines and PrPSc load with disease progression will suggest local hepcidin as the cause of iron accumulation. Moreover, a marked reduction in neuronal and RGC death in hepc-/- mice will suggest a significant role of iron in inducing neurotoxicity, and justify the use of hepcidin antagonists and Fpn stabilizing agents to reduce accumulated iron as therapeutic options. No change in iron levels in hepc-/- mice will refute our hypothesis, and suggest iron as an epiphenomenon of the disease process.

朊病毒病是一种传染性的、致命的神经退行性疾病，与朊病毒的积累有关。 PrP-scrapie (PrPSc)，一种富含 β-折叠的正常朊病毒蛋白 (PrPC) 亚型，存在于人类大脑和视网膜中散发性克雅氏病 (sCJD) 是最常见的人类朊病毒。疾病和 PrPSc 感染的动物模型用于了解感染性和毒性的机制。神经炎症和铁积累是这些疾病的一致特征，后者导致然而，铁催化的活性氧（ROS）引起的神经毒性是铁积累的原因。我实验室的最新数据表明细胞因子介导的铁调素上调。星形胶质细胞合成的 Hepcidin 通过下调铁转运蛋白 (Fpn) 来调节铁，唯一已知的铁输出蛋白，在正常情况下，当铁饱和时，铁调素的表达上调。然而，转铁蛋白 (Tf-Fe) 的上调作用可能会取代 Tf-Fe 的信号。星形胶质细胞细胞因子介导的铁调素上调是表达铁的神经元积累的原因质膜上的 Fpn 和 ROS 的毒性支持了这一假设，sCJD 脑匀浆。显示铁调素 mRNA 和蛋白质的上调、Fpn 的下调以及铁蛋白的增加，同样，大脑。 PrPSc 感染小鼠的匀浆显示铁调素 mRNA 上调，PrPSc 的视网膜切片显示铁调素 mRNA 上调受感染的仓鼠在疾病期间铁蛋白上调之前或同时表现出小胶质细胞的激活基于这些观察，我们发现 sCJD 和 PrPSc 感染者中的铁积累大脑和视网膜是细胞因子介导的局部铁调素上调的结果。提出了两个具体目标。为了检验这一假设，将检查额外的 sCJD 大脑和视网膜组织中铁调素的增加。 mRNA 和铁的积累，并与神经和视网膜神经节细胞 (RGC) 死亡相关此外，将在疾病期间检查 PrPSc 感染小鼠的大脑和视网膜。探讨细胞因子进展的增加是否会上调铁调素和铁积累，以及视网膜变性是否先于神经变性这将为视网膜成像前期铺平道路。 sCJD 的临床诊断测试在目标 2 中，铁调素在大脑和视网膜铁积累中的作用将得到进一步研究。使用接种 PrPSc A 的铁调素敲除小鼠 (hepc-/-) 和同窝小鼠 (hepc+/+) 对照小鼠进行研究。与 hepc+/+ 对照相比，hepc-/- 小鼠的铁积累显着减少，尽管随着疾病进展，细胞因子和 PrPSc 负荷表明局部铁调素是铁积累的原因。此外，hepc-/- 小鼠神经和 RGC 死亡的显着减少表明铁在诱导神经毒性，并证明使用铁调素拮抗剂和 Fpn 稳定剂以减少 hepc-/- 小鼠体内铁水平的变化不会反驳我们的假设，并且建议铁作为疾病过程的附带现象。